iShares Biotechnology ETF
711 hedge funds and large institutions have $6.41B invested in iShares Biotechnology ETF in 2019 Q4 according to their latest regulatory filings, with 172 funds opening new positions, 153 increasing their positions, 231 reducing their positions, and 48 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
5.66% more ownership
Funds ownership: 78.5% → 84.16% (+5.7%)
34% less repeat investments, than reductions
Existing positions increased: 153 | Existing positions reduced: 231
43% less call options, than puts
Call options by funds: $692M | Put options by funds: $1.22B
Holders
711
Holding in Top 10
11
Calls
$692M
Puts
$1.22B
Top Buyers
| 1 | +$207M | |
| 2 | +$207M | |
| 3 | +$166M | |
| 4 |
Public Sector Pension Investment Board (PSP Investments)
Montreal,
Quebec, Canada
|
+$34.7M |
| 5 |
SMM
Stadion Money Management
Watkinsville,
Georgia
|
+$27.1M |
Top Sellers
| 1 | -$224M | |
| 2 | -$195M | |
| 3 | -$170M | |
| 4 |
N
Natixis
Paris,
France
|
-$125M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$68.9M |